These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The p38 mitogen activated protein kinase regulates β-amyloid protein internalization through the α7 nicotinic acetylcholine receptor in mouse brain. Ma KG, Lv J, Yang WN, Chang KW, Hu XD, Shi LL, Zhai WY, Zong HF, Qian YH. Brain Res Bull; 2018 Mar; 137():41-52. PubMed ID: 29128415 [Abstract] [Full Text] [Related]
5. Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway. Wang XL, Deng YX, Gao YM, Dong YT, Wang F, Guan ZZ, Hong W, Qi XL. Aging (Albany NY); 2020 Jan 06; 12(1):543-570. PubMed ID: 31905173 [Abstract] [Full Text] [Related]
6. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease. Hernandez CM, Kayed R, Zheng H, Sweatt JD, Dineley KT. J Neurosci; 2010 Feb 17; 30(7):2442-53. PubMed ID: 20164328 [Abstract] [Full Text] [Related]
7. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease. Takata K, Amamiya T, Mizoguchi H, Kawanishi S, Kuroda E, Kitamura R, Ito A, Saito Y, Tawa M, Nagasawa T, Okamoto H, Sugino Y, Takegami S, Kitade T, Toda Y, Kem WR, Kitamura Y, Shimohama S, Ashihara E. Neurobiol Aging; 2018 Feb 17; 62():197-209. PubMed ID: 29175709 [Abstract] [Full Text] [Related]
9. PNU282987 inhibits amyloid‑β aggregation by upregulating astrocytic endogenous αB‑crystallin and HSP‑70 via regulation of the α7AChR, PI3K/Akt/HSF‑1 signaling axis. Ren Z, Dong Z, Xie P, Lv J, Hu Y, Guan Z, Zhang C, Yu W. Mol Med Rep; 2020 Jul 17; 22(1):201-208. PubMed ID: 32377707 [Abstract] [Full Text] [Related]
10. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A. Neurodegener Dis; 2010 Jul 17; 7(6):379-88. PubMed ID: 20689242 [Abstract] [Full Text] [Related]
11. Inflammation decreases the level of alpha7 nicotinic acetylcholine receptors in the brain mitochondria and makes them more susceptible to apoptosis induction. Lykhmus O, Gergalova G, Zouridakis M, Tzartos S, Komisarenko S, Skok M. Int Immunopharmacol; 2015 Nov 17; 29(1):148-51. PubMed ID: 25887272 [Abstract] [Full Text] [Related]
12. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells. Ren JM, Zhang SL, Wang XL, Guan ZZ, Qi XL. Mol Med Rep; 2020 Sep 17; 22(3):2063-2075. PubMed ID: 32582986 [Abstract] [Full Text] [Related]
13. Tyrosine phosphatase STEP61 negatively regulates amyloid β-mediated ERK/CREB signaling pathways via α7 nicotinic acetylcholine receptors. Zhang L, Xie JW, Yang J, Cao YP. J Neurosci Res; 2013 Dec 17; 91(12):1581-90. PubMed ID: 24123152 [Abstract] [Full Text] [Related]
14. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice. Sadigh-Eteghad S, Talebi M, Mahmoudi J, Babri S, Shanehbandi D. Neuroscience; 2015 Jul 09; 298():81-93. PubMed ID: 25881725 [Abstract] [Full Text] [Related]
15. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction. Roberts JP, Stokoe SA, Sathler MF, Nichols RA, Kim S. J Biol Chem; 2021 Jul 09; 296():100402. PubMed ID: 33571523 [Abstract] [Full Text] [Related]
16. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease. Shen J, Wu J. Int Rev Neurobiol; 2015 Jul 09; 124():275-92. PubMed ID: 26472533 [Abstract] [Full Text] [Related]
17. The Abeta1-42M35C mutated amyloid peptide Abeta1-42 and the 25-35 fragment fail to mimic the subtype-specificity of actions on recombinant human nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4). Pym LJ, Buckingham SD, Tsetlin V, Boyd CA, Sattelle DB. Neurosci Lett; 2007 Oct 29; 427(1):28-33. PubMed ID: 17945421 [Abstract] [Full Text] [Related]
18. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease. Ikonomovic MD, Wecker L, Abrahamson EE, Wuu J, Counts SE, Ginsberg SD, Mufson EJ, Dekosky ST. Arch Neurol; 2009 May 29; 66(5):646-51. PubMed ID: 19433665 [Abstract] [Full Text] [Related]
19. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease. Oz M, Lorke DE, Yang KH, Petroianu G. Curr Alzheimer Res; 2013 Jul 29; 10(6):618-30. PubMed ID: 23627750 [Abstract] [Full Text] [Related]
20. The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42. Søderman A, Thomsen MS, Hansen HH, Nielsen EØ, Jensen MS, West MJ, Mikkelsen JD. Brain Res; 2008 Aug 28; 1227():240-7. PubMed ID: 18619425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]